Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus... In concert with efforts to increase global provision, economic evaluations of newer and relatively costly vaccines have proliferated in the medical literature. The extent to which existing vaccine evaluations are useful to decision makers is not clear. We conducted a systematic review of published economic evaluations of conjugate Haemophilus influenzae type b (Hib) vaccine, anticipating that their usefulness to past and present decision makers would be limited by the quality of the analyses and by the extent to which the results were transferable to other settings. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Pediatric infectious disease journal Pubmed

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.

The Pediatric infectious disease journal , Volume 23 (1): 6 – Feb 26, 2004

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.


Abstract

In concert with efforts to increase global provision, economic evaluations of newer and relatively costly vaccines have proliferated in the medical literature. The extent to which existing vaccine evaluations are useful to decision makers is not clear. We conducted a systematic review of published economic evaluations of conjugate Haemophilus influenzae type b (Hib) vaccine, anticipating that their usefulness to past and present decision makers would be limited by the quality of the analyses and by the extent to which the results were transferable to other settings.

Loading next page...
 
/lp/pubmed/are-economic-evaluations-of-vaccines-useful-to-decision-makers-case-061UIYfY13

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0891-3668
DOI
10.1097/01.inf.0000105104.39284.a3
pmid
14743043

Abstract

In concert with efforts to increase global provision, economic evaluations of newer and relatively costly vaccines have proliferated in the medical literature. The extent to which existing vaccine evaluations are useful to decision makers is not clear. We conducted a systematic review of published economic evaluations of conjugate Haemophilus influenzae type b (Hib) vaccine, anticipating that their usefulness to past and present decision makers would be limited by the quality of the analyses and by the extent to which the results were transferable to other settings.

Journal

The Pediatric infectious disease journalPubmed

Published: Feb 26, 2004

There are no references for this article.